搜索临床试验以:派姆单抗和甲磺酸伊马替尼
总计4574个结果
-
National Cancer Institute (NCI)Gynecologic Oncology Group完全的
-
National Cancer Institute (NCI)完全的复发性黑色素瘤 | IV 期黑色素瘤 | IIIA期黑色素瘤 | IIIB期黑色素瘤 | IIIC期黑色素瘤 | 肢端黑色素瘤美国
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的
-
Amneal Pharmaceuticals, LLCAccutest Research Laboratories (I) Pvt. Ltd.完全的
-
Novartis Pharmaceuticals主动,不招人GIST 和 CML中国, 芬兰, 火鸡, 新加坡, 法国, 瑞士, 泰国, 罗马尼亚, 香港, 英国, 美国
-
Peking University完全的
-
National Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)完全的
-
Memorial Sloan Kettering Cancer Center主动,不招人
-
CttqRuijin Hospital未知
-
M.D. Anderson Cancer CenterNovartis完全的
-
Gruppo Italiano Malattie EMatologiche dell'Adulto完全的
-
Centre Oscar LambretNovartis; National Cancer Institute, France终止
-
Azienda Ospedaliera Universitaria PoliclinicoUniversità Politecnica delle Marche未知
-
Central European Leukemia Study Group未知
-
Joanne JeterNational Cancer Institute (NCI); Merck Ltd.撤销IV 期皮肤黑色素瘤 | IIIB 期皮肤黑色素瘤 | IIIC 期皮肤黑色素瘤 | IIIA 期皮肤黑色素瘤
-
Novartis Pharmaceuticals完全的
-
Samsung Medical Center主动,不招人
-
Abramson Cancer Center at Penn MedicineNovartis Pharmaceuticals终止
-
Medical University of South CarolinaColumbia University完全的
-
National Taiwan University HospitalNational Cheng-Kung University Hospital; Far Eastern Memorial Hospital; Tri-Service General Hospital 和其他合作者终止
-
Shanghai Zhongshan HospitalChanghai Hospital; Fudan University; Huashan Hospital; Ruijin Hospital; Shanghai Changzheng Hospital未知Method of Differentiating Benignancy and Malignancy, Grading and Staging for GIST中国
-
Dana-Farber Cancer InstituteNovartis完全的
-
Università degli Studi di Brescia完全的
-
University of California, Los AngelesNovartis Pharmaceuticals完全的